Ligand-gated ion channel

Source: Wikipedia, the free encyclopedia.
(Redirected from
Ionotropic receptor
)
Neurotransmitter-gated ion-channel transmembrane region
TCDB
1.A.9
OPM superfamily14
OPM protein2bg9
Available protein structures:
Pfam  structures / ECOD  
PDBRCSB PDB; PDBe; PDBj
PDBsumstructure summary
Ions
  • Ligand (such as acetylcholine)
  • When ligands bind to the receptor, the ion channel portion of the receptor opens, allowing ions to pass across the cell membrane
    .
    Ligand-gated ion channel showing the binding of transmitter (Tr) and changing of membrane potential (Vm)

    Ligand-gated ion channels (LICs, LGIC), also commonly referred to as ionotropic receptors, are a group of

    ion-channel proteins which open to allow ions such as Na+, K+, Ca2+, and/or Cl to pass through the membrane in response to the binding of a chemical messenger (i.e. a ligand), such as a neurotransmitter.[1][2][3]

    When a

    postsynaptic neuron. If these receptors are ligand-gated ion channels, a resulting conformational change opens the ion channels, which leads to a flow of ions across the cell membrane. This, in turn, results in either a depolarization, for an excitatory receptor response, or a hyperpolarization
    , for an inhibitory response.

    These receptor proteins are typically composed of at least two different domains: a transmembrane domain which includes the ion pore, and an extracellular domain which includes the ligand binding location (an

    .

    Cys-loop receptors

    Nicotinic acetylcholine receptor in closed state with predicted membrane boundaries shown, PDB 2BG9

    The

    cys-loop receptors are named after a characteristic loop formed by a disulfide bond between two cysteine
    residues in the N terminal extracellular domain. They are part of a larger family of pentameric ligand-gated ion channels that usually lack this disulfide bond, hence the tentative name "Pro-loop receptors".[4][5] A binding site in the extracellular N-terminal ligand-binding domain gives them receptor specificity for (1) acetylcholine (AcCh), (2) serotonin, (3) glycine, (4) glutamate and (5) γ-aminobutyric acid (GABA) in vertebrates. The receptors are subdivided with respect to the type of ion that they conduct (anionic or cationic) and further into families defined by the endogenous ligand. They are usually pentameric with each subunit containing 4 transmembrane helices constituting the transmembrane domain, and a beta sheet sandwich type, extracellular, N terminal, ligand binding domain.[6] Some also contain an intracellular domain like shown in the image.

    The prototypic ligand-gated ion channel is the nicotinic acetylcholine receptor. It consists of a pentamer of protein subunits (typically ααβγδ), with two binding sites for acetylcholine (one at the interface of each alpha subunit). When the acetylcholine binds it alters the receptor's configuration (twists the T2 helices which moves the leucine residues, which block the pore, out of the channel pathway) and causes the constriction in the pore of approximately 3 angstroms to widen to approximately 8 angstroms so that ions can pass through. This pore allows Na+ ions to flow down their electrochemical gradient into the cell. With a sufficient number of channels opening at once, the inward flow of positive charges carried by Na+ ions depolarizes the postsynaptic membrane sufficiently to initiate an action potential.

    A bacterial homologue to an LIC has been identified, hypothesized to act nonetheless as a chemoreceptor.[4] This prokaryotic nAChR variant is known as the GLIC receptor, after the species in which it was identified; Gloeobacter Ligand-gated Ion Channel.

    Structure

    Cys-loop receptors have structural elements that are well conserved, with a large extracellular domain (ECD) harboring an alpha-helix and 10 beta-strands. Following the ECD, four transmembrane segments (TMSs) are connected by intracellular and extracellular loop structures.[7] Except the TMS 3-4 loop, their lengths are only 7-14 residues. The TMS 3-4 loop forms the largest part of the intracellular domain (ICD) and exhibits the most variable region between all of these homologous receptors. The ICD is defined by the TMS 3-4 loop together with the TMS 1-2 loop preceding the ion channel pore.[7] Crystallization has revealed structures for some members of the family, but to allow crystallization, the intracellular loop was usually replaced by a short linker present in prokaryotic cys-loop receptors, so their structures as not known. Nevertheless, this intracellular loop appears to function in desensitization, modulation of channel physiology by pharmacological substances, and posttranslational modifications. Motifs important for trafficking are therein, and the ICD interacts with scaffold proteins enabling inhibitory synapse formation.[7]

    Cationic cys-loop receptors

    Type Class IUPHAR-recommended
    protein name [8]
    Gene Previous names
    Serotonin

    (5-HT)
    5-HT3 5-HT3A
    5-HT3B
    5-HT3C
    5-HT3D
    5-HT3E
    HTR3A
    HTR3B
    HTR3C
    HTR3D
    HTR3E
    5-HT3A
    5-HT3B
    5-HT3C
    5-HT3D
    5-HT3E
    Nicotinic acetylcholine
    (nAChR)
    alpha CHRNA1
    CHRNA2
    CHRNA3
    CHRNA4
    CHRNA5
    CHRNA6
    CHRNA7
    CHRNA9
    CHRNA10
    ACHRA, ACHRD, CHRNA, CMS2A, FCCMS, SCCMS







    beta β1
    β2
    β3
    β4
    CHRNB1
    CHRNB2
    CHRNB3
    CHRNB4
    CMS2A, SCCMS, ACHRB, CHRNB, CMS1D
    EFNL3, nAChRB2

    gamma γ CHRNG ACHRG
    delta δ CHRND ACHRD, CMS2A, FCCMS, SCCMS
    epsilon ε CHRNE ACHRE, CMS1D, CMS1E, CMS2A, FCCMS, SCCMS
    Zinc-activated ion channel
    (ZAC)
    ZAC ZACN ZAC1, L2m LICZ, LICZ1

    Anionic cys-loop receptors

    Type Class IUPHAR-recommended
    protein name[8]
    Gene Previous names
    GABAA alpha GABRA1
    GABRA2
    GABRA3
    GABRA4
    GABRA5
    GABRA6
    EJM, ECA4
    beta β1
    β2
    β3
    GABRB1
    GABRB2
    GABRB3


    ECA5
    gamma
    γ2
    γ3

    GABRG1
    GABRG2
    GABRG3
    CAE2, ECA2, GEFSP3
    delta δ GABRD
    epsilon ε GABRE
    pi π GABRP
    theta θ GABRQ
    rho ρ1
    ρ2
    ρ3
    GABRR1
    GABRR2
    GABRR3
    GABAC[9]
    Glycine
    (GlyR)
    alpha GLRA1
    GLRA2
    GLRA3
    GLRA4
    STHE

    beta β GLRB

    Ionotropic glutamate receptors

    The ionotropic glutamate receptors bind the neurotransmitter glutamate. They form tetramers, with each subunit consisting of an extracellular amino terminal domain (ATD, which is involved tetramer assembly), an extracellular ligand binding domain (LBD, which binds glutamate), and a transmembrane domain (TMD, which forms the ion channel). The transmembrane domain of each subunit contains three transmembrane helices as well as a half membrane helix with a reentrant loop. The structure of the protein starts with the ATD at the N terminus followed by the first half of the LBD which is interrupted by helices 1,2 and 3 of the TMD before continuing with the final half of the LBD and then finishing with helix 4 of the TMD at the C terminus. This means there are three links between the TMD and the extracellular domains. Each subunit of the tetramer has a binding site for glutamate formed by the two LBD sections forming a clamshell like shape. Only two of these sites in the tetramer need to be occupied to open the ion channel. The pore is mainly formed by the half helix 2 in a way which resembles an inverted potassium channel.

    The AMPA receptor bound to a glutamate antagonist showing the amino terminal, ligand binding, and transmembrane domain, PDB 3KG2
    Type Class IUPHAR-recommended
    protein name [8]
    Gene Previous names
    AMPA GluA GluA1
    GluA2
    GluA3
    GluA4
    GRIA1
    GRIA2
    GRIA3
    GRIA4
    GLUA1, GluR1, GluRA, GluR-A, GluR-K1, HBGR1
    GLUA2, GluR2, GluRB, GluR-B, GluR-K2, HBGR2
    GLUA3, GluR3, GluRC, GluR-C, GluR-K3
    GLUA4, GluR4, GluRD, GluR-D
    Kainate GluK GluK1
    GluK2
    GluK3
    GluK4
    GluK5
    GRIK1
    GRIK2
    GRIK3
    GRIK4
    GRIK5
    GLUK5, GluR5, GluR-5, EAA3
    GLUK6, GluR6, GluR-6, EAA4
    GLUK7, GluR7, GluR-7, EAA5
    GLUK1, KA1, KA-1, EAA1
    GLUK2, KA2, KA-2, EAA2
    NMDA GluN GluN1
    NRL1A
    NRL1B
    GRIN1
    GRINL1A
    GRINL1B
    GLUN1, NMDA-R1, NR1, GluRξ1


    GluN2A
    GluN2B
    GluN2C
    GluN2D
    GRIN2A
    GRIN2B
    GRIN2C
    GRIN2D
    GLUN2A, NMDA-R2A, NR2A, GluRε1
    GLUN2B, NMDA-R2B, NR2B, hNR3, GluRε2
    GLUN2C, NMDA-R2C, NR2C, GluRε3
    GLUN2D, NMDA-R2D, NR2D, GluRε4
    GluN3A
    GluN3B
    GRIN3A
    GRIN3B
    GLUN3A, NMDA-R3A, NMDAR-L, chi-1
    GLU3B, NMDA-R3B
    ‘Orphan’ (GluD) GluD1
    GluD2
    GRID1
    GRID2
    GluRδ1
    GluRδ2

    AMPA receptor

    AMPA receptor trafficking

    The α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (also known as

    glutamate that mediates fast synaptic transmission in the central nervous system
    (CNS). Its name is derived from its ability to be activated by the artificial glutamate analog
    crystallized
    . Ligands include:

    NMDA receptors

    Stylized depiction of an activated NMDAR

    The N-methyl-D-aspartate receptor (

    D-serine or glycine).[11] Studies show that the NMDA receptor is involved in regulating synaptic plasticity and memory.[12][13]

    The name "NMDA receptor" is derived from the ligand

    cation channel opens, allowing Na+ and Ca2+ to flow into the cell, in turn raising the cell's electric potential. Thus, the NMDA receptor is an excitatory receptor. At resting potentials, the binding of Mg2+ or Zn2+ at their extracellular binding sites on the receptor blocks ion flux through the NMDA receptor channel. "However, when neurons are depolarized, for example, by intense activation of colocalized postsynaptic AMPA receptors, the voltage-dependent block by Mg2+ is partially relieved, allowing ion influx through activated NMDA receptors. The resulting Ca2+ influx can trigger a variety of intracellular signaling cascades, which can ultimately change neuronal function through activation of various kinases and phosphatases".[14]
    Ligands include:

    ATP-gated channels

    Figure 1. Schematic representation showing the membrane topology of a typical P2X receptor subunit. First and second transmembrane domains are labeled TM1 and TM2.

    ATP-gated channels open in response to binding the nucleotide ATP. They form trimers with two transmembrane helices per subunit and both the C and N termini on the intracellular side.

    Type Class IUPHAR-recommended
    protein name [8]
    Gene Previous names
    P2X
    N/A P2X1
    P2X2
    P2X3
    P2X4
    P2X5
    P2X6
    P2X7
    P2RX1
    P2RX2
    P2RX3
    P2RX4
    P2RX5
    P2RX6
    P2RX7
    P2X1
    P2X2
    P2X3
    P2X4
    P2X5
    P2X6
    P2X7

    Clinical relevance

    Ligand-gated ion channels are likely to be the major site at which

    anaesthetic agents at concentrations similar to those used in clinical anaesthesia.[18]

    By understanding the mechanism and exploring the chemical/biological/physical component that could function on those receptors, more and more clinical applications are proven by preliminary experiments or

    FDA. Memantine is approved by the U.S. F.D.A and the European Medicines Agency for the treatment of moderate-to-severe Alzheimer's disease,[19] and has now received a limited recommendation by the UK's National Institute for Health and Care Excellence for patients who fail other treatment options.[20] Agomelatine, is a type of drug that acts on a dual melatonergic-serotonergic pathway, which have shown its efficacy in the treatment of anxious depression during clinical trials,[21][22] study also suggests the efficacy in the treatment of atypical and melancholic depression.[23]

    See also

    References

    1. ^ "Gene Family: Ligand gated ion channels". HUGO Gene Nomenclature Committee.
    2. ^ "ligand-gated channel" at Dorland's Medical Dictionary
    3. ISBN 978-0-87893-697-7.{{cite book}}: CS1 maint: multiple names: authors list (link
      )
    4. ^ .
    5. .
    6. .
    7. ^ .
    8. ^ .
    9. .
    10. .
    11. . At membrane potentials more negative than approximately −50 mV, the Mg2+ in the extracellular fluid of the brain virtually abolishes ion flux through NMDA receptor channels, even in the presence of glutamate. ... The NMDA receptor is unique among all neurotransmitter receptors in that its activation requires the simultaneous binding of two different agonists. In addition to the binding of glutamate at the conventional agonist-binding site, the binding of glycine appears to be required for receptor activation. Because neither of these agonists alone can open this ion channel, glutamate and glycine are referred to as coagonists of the NMDA receptor. The physiologic significance of the glycine binding site is unclear because the normal extracellular concentration of glycine is believed to be saturating. However, recent evidence suggests that D-serine may be the endogenous agonist for this site.
    12. .
    13. .
    14. .
    15. .
    16. .
    17. .
    18. .
    19. .
    20. ^ NICE technology appraisal January 18, 2011 Azheimer's disease - donepezil, galantamine, rivastigmine and memantine (review): final appraisal determination
    21. S2CID 144761669
      .
    22. .
    23. .

    External links

    As of this edit, this article uses content from "1.A.9 The Neurotransmitter Receptor, Cys loop, Ligand-gated Ion Channel (LIC) Family", which is licensed in a way that permits reuse under the

    Creative Commons Attribution-ShareAlike 3.0 Unported License, but not under the GFDL
    . All relevant terms must be followed.